Literature DB >> 25079013

Transplantation of pulmonary valve using a mouse model of heterotopic heart transplantation.

Yong-Ung Lee1, Tai Yi2, Iyore James2, Shuhei Tara2, Alexander J Stuber2, Kejal V Shah2, Avione Y Lee2, Tadahisa Sugiura2, Narutoshi Hibino3, Toshiharu Shinoka2, Christopher K Breuer4.   

Abstract

Tissue engineered heart valves, especially decellularized valves, are starting to gain momentum in clinical use of reconstructive surgery with mixed results. However, the cellular and molecular mechanisms of the neotissue development, valve thickening, and stenosis development are not researched extensively. To answer the above questions, we developed a murine heterotopic heart valve transplantation model. A heart valve was harvested from a valve donor mouse and transplanted to a heart donor mouse. The heart with a new valve was transplanted heterotopically to a recipient mouse. The transplanted heart showed its own heartbeat, independent of the recipient's heartbeat. The blood flow was quantified using a high frequency ultrasound system with a pulsed wave Doppler. The flow through the implanted pulmonary valve showed forward flow with minimal regurgitation and the peak flow was close to 100 mm/sec. This murine model of heart valve transplantation is highly versatile, so it can be modified and adapted to provide different hemodynamic environments and/or can be used with various transgenic mice to study neotissue development in a tissue engineered heart valve.

Entities:  

Mesh:

Year:  2014        PMID: 25079013      PMCID: PMC4407638          DOI: 10.3791/51695

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

Review 1.  Choice of prosthetic heart valve in today's practice.

Authors:  Reida El Oakley; Peter Kleine; David S Bach
Journal:  Circulation       Date:  2008-01-15       Impact factor: 29.690

2.  Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.

Authors:  T Shinoka; P X Ma; D Shum-Tim; C K Breuer; R A Cusick; G Zund; R Langer; J P Vacanti; J E Mayer
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

3.  Beyond transplantation. Third annual Samuel Jason Mixter lecture.

Authors:  J P Vacanti
Journal:  Arch Surg       Date:  1988-05

4.  Tissue engineering heart valves: valve leaflet replacement study in a lamb model.

Authors:  T Shinoka; C K Breuer; R E Tanel; G Zund; T Miura; P X Ma; R Langer; J P Vacanti; J E Mayer
Journal:  Ann Thorac Surg       Date:  1995-12       Impact factor: 4.330

5.  Evaluation of biodegradable, three-dimensional matrices for tissue engineering of heart valves.

Authors:  R Sodian; S P Hoerstrup; J S Sperling; D P Martin; S Daebritz; J E Mayer; J P Vacanti
Journal:  ASAIO J       Date:  2000 Jan-Feb       Impact factor: 2.872

6.  Tissue engineering of heart valves: in vitro experiences.

Authors:  R Sodian; S P Hoerstrup; J S Sperling; S H Daebritz; D P Martin; F J Schoen; J P Vacanti; J E Mayer
Journal:  Ann Thorac Surg       Date:  2000-07       Impact factor: 4.330

7.  Early in vivo experience with tissue-engineered trileaflet heart valves.

Authors:  R Sodian; S P Hoerstrup; J S Sperling; S Daebritz; D P Martin; A M Moran; B S Kim; F J Schoen; J P Vacanti; J E Mayer
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

8.  Increased morbidity and mortality in very preterm/VLBW infants with congenital heart disease.

Authors:  Angelo Polito; Simone Piga; Paola E Cogo; Carlo Corchia; Virgilio Carnielli; Monica Da Frè; Domenico Di Lallo; Isabella Favia; Luigi Gagliardi; Francesco Macagno; Silvana Miniaci; Marina Cuttini
Journal:  Intensive Care Med       Date:  2013-03-28       Impact factor: 17.440

9.  Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk.

Authors:  Martijn W A van Geldorp; W R Eric Jamieson; A Pieter Kappetein; Jian Ye; Guy J Fradet; Marinus J C Eijkemans; Gary L Grunkemeier; Ad J J C Bogers; Johanna J M Takkenberg
Journal:  J Thorac Cardiovasc Surg       Date:  2009-02-25       Impact factor: 5.209

10.  Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations.

Authors:  C Wren; Z Reinhardt; K Khawaja
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-06-07       Impact factor: 5.747

View more
  4 in total

1.  Tissue-Engineered Heart Valves: A Call for Mechanistic Studies.

Authors:  Kevin M Blum; Joseph D Drews; Christopher K Breuer
Journal:  Tissue Eng Part B Rev       Date:  2018-02-13       Impact factor: 6.389

2.  Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves.

Authors:  Iyore A James; Tai Yi; Shuhei Tara; Cameron A Best; Alexander J Stuber; Kejal V Shah; Blair F Austin; Tadahisa Sugiura; Yong-Ung Lee; Joy Lincoln; Aaron J Trask; Toshiharu Shinoka; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2015-05-29       Impact factor: 3.056

Review 3.  The Real Need for Regenerative Medicine in the Future of Congenital Heart Disease Treatment.

Authors:  Yuichi Matsuzaki; Matthew G Wiet; Brian A Boe; Toshiharu Shinoka
Journal:  Biomedicines       Date:  2021-04-27

Review 4.  Tissue engineering: Relevance to neonatal congenital heart disease.

Authors:  Kevin M Blum; Gabriel J M Mirhaidari; Christopher K Breuer
Journal:  Semin Fetal Neonatal Med       Date:  2021-02-27       Impact factor: 3.726

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.